Liquid biopsy-based multiomics profiling using low-pass whole genome sequencing and proteomics with computational modeling reveals molecular features of disease severity in EGFR/ALK wildtype NSCLC patients
Feng Z, Wang D, Vallania F, Smith N, Tripathi A, Scheuenpflug J
